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Abstract
Introduction and purpose of the study With this study we
aimed to describe a “true world” picture of severe pae-
diatric ‘community-acquired’ septic shock and establish
the feasibility of a future prospective trial on early goal-
directed therapy in children. During a 6-month to 1-year
retrospective screening period in 16 emergency depart-
ments (ED) in 12 different countries, all children with
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severe sepsis and signs of decreased perfusion were
included.
Results A 270,461 paediatric ED consultations were
screened, and 176 cases were identified. Significant comor-
bidity was present in 35.8 % of these cases. Intensive care
admission was deemed necessary in 65.7 %, mechanical
ventilation in 25.9 % and vasoactive medications in
42.9 %. The median amount of fluid given in the first 6 h
was 30 ml/kg. The overall mortality in this sample was
4.5 %. Only 1.2 % of the survivors showed a substantial
decrease in Paediatric Overall Performance Category
(POPC). ‘Severe’ outcome (death or a decrease ≥2 in
POPC) was significantly related (p<0.01) to: any desatura-
tion below 90 %, the amount of fluid given in the first 6 h,
the need for and length of mechanical ventilation or vaso-
active support, the use of dobutamine and a higher lactate or
lower base excess but not to any variables of predisposition,
infection or host response (as in the PIRO (Predisposition,
Infection, Response, Organ dysfunction) concept).
Conclusion The outcome in our sample was very good.Many
children received treatment early in their disease course, so
avoiding subsequent intensive care. While certain varia-
bles predispose children to become septic and shocked,
in our sample, only measures of organ dysfunction and
concomitant treatment proved to be significantly related
with outcome. We argue why future studies should rather
be large multinational prospective observational trials and not
necessarily randomised controlled trials.
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Introduction
Sepsis is still an important health problem in children, with a
hospital mortality of 3–10 % in ‘developed’ countries and
up to 15–30 % when shock is present [2, 9, 23, 25]. Existing
figures rarely include children who die or are fully resusci-
tated before reaching the paediatric intensive care unit
(PICU) or provide information about attributed long-term
morbidity [2, 9]. Most often, septic patients present initially
to the emergency department (ED), where they should be
recognized and where early aggressive resuscitation can
make a difference [21].
This study therefore aims to describe an ED picture of
severe paediatric community-acquired septic shock. It can
serve as a ‘true world’ baseline, accounting for a potential
Hawthorne effect1 in any subsequent prospective trial and
will help in establishing the feasibility of such a trial on,
for instance, early goal-directed therapy (EGDT) in children
[2, 18].
Methods
This is a retrospective observational study in 16 ED from 12
countries. It was conceived as the first part of a study that
will evaluate EGDT guideline compliance and subsequent
patient outcomes. Institutional ethics committee approval
was obtained in each centre. As data were rendered anony-
mous before handling, a waiver of consent was granted.
Patients were screened for eligibility backwards from a
centre-specific starting date (between September 2011 and
May 2010). All centres screened a 1-year period except for
three centres that, because of logistics and data quality, only
screened a period of 9 and 6 months, respectively (Table 1).
Cases were identified using data from ED or secondary
transfer logs, microbiology and/or pharmacology registries,
in view of local availability, and then evaluated whether
they met all inclusion and any exclusion criteria (Table 2).
Data focussed on the first hours of sepsis and are chro-
nological from first symptoms, first participating ED bed-
side contact [T0] to final outcome at discharge, as defined
by the Paediatric Overall Performance Category (POPC): a
six-level description of the degree of functional/cerebral
disability from normal to death [5]. An operational manual
provided definitions and normal values where needed [7].
Case report forms were controlled for eligibility, complete-
ness and internal consistency by the principal investigator
(PVDV). Electronic data input was performed centrally (UH
Ghent, Belgium) using SNAP software [19].
Primary data analysis
All analyses were performed in StatsDirect software [20].
Unknown data are reported but excluded from further cal-
culations. Nominal data are given as percentages of the total
sample. For continuous variables, we calculated mean and
standard deviation (SD). To explore the relations between
these variables and ‘severe’ outcome, a 95 % confidence
interval (CI) is given for the difference between means,
using the unpaired Student’s t test. We defined ‘severe’
outcome as death and/or a decrease in POPC of 2 or more.
Tests for association between pairs of categorical variables
were performed, using the Fisher exact test. For selected
variables, we also calculated a 95 % CI for the difference
between proportions, using the iterative method of
Miettinen and Nurminen [13]. Ordinal data are presented
as median and interquartile range (IQR). The hypothesis of
equality of medians was tested using a Mann–Whitney U
test. Pvalues smaller than 0.05 were considered significant.
1 A temporary change in behaviour or performance in response to a
change in the environmental conditions like for instance increased
observation or appreciation of that performance.
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Reported Pvalues are only exploratory, and hence, no cor-
rection for multiple testing was done. Given the low number
of ‘severe outcome’ patients within the sample, we refrained
from any further logistic regression analysis [17].
Results
Study subjects
Excluding two centres because of low data quality, 16 centres
participated to the study (five Belgian, one Dutch, one French,
one Saudi, one Turkish, one American, one British, one
Spanish, one Portuguese, one Swiss, one Italian, one Israeli).
Although most of these were tertiary referral hospitals, the
number of children seen in the ED, the percentage of subse-
quent hospital admissions and the number of secondary trans-
fers varied substantially (Table 1). Ultimately, 176 cases were
included, 10.8 % of which after transfer from another hospital.
Most cases presented during the day, with only 19.3 % be-
tween 22.00 h and 07.00 h. The median age of the sample was
2 years; the number of boys and girls equally distributed
(Table 3). Significant comorbidity was present in 35.8 %;
the baseline POPC showed moderate disability in 6.2 % and
severe disability in 4.5 % of cases.
Table 1 Centre specifics and cases included per centre
Centre Final
inclusions
Approx. paediatric non-traumatic
ED consults in same time n
% Hospital
admissions
Sec. transfer, n Severe
outcome
AX 15 3,366 27 % 280 1
BWa 15 4,341 17 % 32 0
CS 5 13,884 22 % 72 1
DE 9 7,200 10 % 176 1
ER 7 16,681 7 % 260 1
GY 12 2,184 17 % 0 1
TFa 19 18,700 17 % 30 0
HP 17 18,000 20 % – 3
ZM 15 22,000 16 % 0 1
JL 10 48,000 4 % 0 0
LH 3 10,800 11.6 % 10 0
MF 13 15,428 17.4 % – 1
PSb 8 20,680 15 % – 0
WZ 16 18,900 12 % 25 0
XT 7 42,737 10 % 70 0
BK 6 7,560 21 % 250 0
16 176 270,461 4–27 % 1,205 10
Different centres had sometimes different screening starting points (between May 2010 and September 2011), but all screened backward for a 1-
year period consecutively. For each centre, we present the approximate number of paediatric non-trauma cases seen in the ED during the
recruitment period and the percentage of hospital admissions in this group, as well as the absolute number of secondary transfers by a team from
the participating ED (en dash if not retraceable). Finally, we give the absolute number of severe outcome cases per centre, defined as cases that died
or had a decrease in POPC of 2 or more
a Due to reasons of logistics and data quality, BW and TF only screened for a 9-month period
b Due to reasons of logistics and data quality, PS only screened for a 6-month period
Table 2 Inclusion and exclusion criteria for case selection [2, 7, 25]
Inclusion:
○ Children between 44 weeks gestational age and 16 years
○ Admission to hospital or death after presenting at the participating
ED (<6 h before) or after secondary transport (admitted in the
referring hospital <6 h at referral)
○ With presumed ‘community-acquired’ sepsis
▪ At least two of four SIRS criteria (as defined by Goldstein et al.) [7]
▪ And the presumed presence of an infection (suspected or proven)
○ And with any sign of decreased perfusion at any moment in the first
6 h of admission: (altered decreased mental status, capillary refill >
2 s or flash, diminished or bounding peripheral pulses, mottled cool
extremities, decreased urinary output <1 ml/kg/h)
Exclusion
○ Patients who are considered palliative
○ Patients who have an uncorrected cyanotic heart disease
○ Patients who have a clear other non-infectious cause for the pre-
senting shock or for whom sepsis is not the primary diagnosis, e.g.
bronchiolitis, seizure disorder, metabolic and/or cardiac aetiologies
○ Insufficient data availability for screening or case report form
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Table 3 Recognised covariates, grouped by PIRO classification, their total sample value in percentage %, median (+ IQR) or mean (+SD), as well
as the values for the group with severe or good outcome and finally their statistical relation to severe outcome
Covariables TOTAL [n=176]: %;
mean (SD) or median (IQR)
Unknown, n Severe outcome
[n=10]
Good outcome
[n=166]
[95 % CI]
Predisposition
Age med. 2 years (0.65–6) 0 0.65 years 2 years [−0.08; 2.7]
Gender 49.5 % male 1 60 % 55.2 % [−24.7 %; 30 %]
Severe comorbidity 35.8 % 11 33.3 % 35.9 % [−24.8 %; 27.6 %]
First contact time T0 14 h (9–18) 2 14.5 h 14 h [−3; 5]
First symptoms med. 30 h before T0 (13–72) 9 42 h 30 h [−24; 20]
Secondary transfer 10.8 % 3 20 % 10.4 % [−6 %; 41 %]
Infection
Meningococcal disease 23.6 % 70 14.3 % 24.2 % [−26.9 %; 27.5 %]
Pneumococcal disease 10.4 % 70 14.3 % 10.1 % [−10.7 %; 41.5 %]
Toxic shock syndrome 7.2 % 23 11.1 % 7 % [−6.7 %; 36.9 %]
Site of infection: brain 15 % 23 33.3 % 13.9 % [−3 %; 51.3 %]
Site of infection: line 5.2 % 23 11.1 % 4.9 % [−4.2 %; 38.9 %]
Site of infection: urine 9.8 % 23 0 % 10.4 % [−16.5 %; 19.9 %]
Host response
White blood cell count Mean, 13,980/μL (10,955) 8 12,932 14,040 [−6323; 8539]
White blood cell <1,000/μl 14.4 % 9 30 % 13.4 % [−3.7 %; 47.5 %]
Thrombocytes <100,000/μl 25.9 % 10 44.4 % 24.8 % [−7.9 %; 46.1 %]
INR (int. normal. ratio) med. 1.61 (1.3–2) 79 1.71 1.6 [−0.86; 0.2]
Glycaemia med. 109.5 g/L (90–152) 26 107 110 [−80; 40]
C-reactive protein mean 18 mg/dl (14.2) 36 23.7 17.8 [−20.2; 8.4]
Organ dysfunction
Any hypotension first 6 h 47.7 % 0 80 % 45.8 % [2.2 %; 51.2 %]*
Any oxygen sat. <90 % first 6 h 33.3 % 17 90 % 29.5 % [29.2 %; 72.3 %]***
Intensive care/HDU admission 65.7 % 1 80 % 62.4 % [−14.4 %; 34.5 %]
Need for mech. ventilation 25.9 % 0 100 % 21.3 % [50.4 %; 84.2 %]***
Length of mech. ventilation med. 0 h (0–0) 2 60 0 [−96;−24]***
Need for vasoactive medic. 42.9 % 0 100 % 39.2 % [32.3 %; 68.1 %]***
Length of vasoactive support med. 0 h (0–22) 8 59 0 [−72; −22]***
Creatinine med. 0.47 mg/dl (0.3–0.85) 12 0.7 0.45 [−0.01; −0.5]*
ALT med. 48 IU/L (26–117) 89 79 46 [−66; 20]
Base excess (mean) mean -8 (6.9) 48 −15.8 −7.5 [−3.5; −13.1]***
Lactate (mg/dl; mean) mean 39.8 mg/dl (32.9) 63 77 37 [17.2; 62.8]***
Treatments provided
Total fluid first 6 h med. 30 ml/kg (18–60) 5 58 30 [10; 50]**
Total fluid first 24 h med. 40 ml/kg (19–66) 11 68 35 [10; 65]**
Total fluid first 6 h>40 ml/kg 43.3 % 5 90 % 40.4 % [18.3 %; 61.7 %]**
Total fluid first 24 h>40 ml/kg 50 % 10 90 % 47.4 % [11.2 %; 55 %]*
Additional fluid bolus after 6 h 20.4 % 14 20 % 20.4 % [−16.9 %; 31.3 %]
Total fluid first h>20 ml/kg 73.7 % 5 100 % 72 % [−0.4 %; 35.4 %]
Any colloid bolus first 24 h 18.2 % 0 50 % 16.3 % [6.5 %; 60.8 %]*
Any blood products first 24 h 22.7 % 0 60 % 20.5 % [9.9 %; 63.8 %]*
Any packed red cells first 24 h 16.6 % 1 60 % 13.9 % [16.7 %; 70 %]*
Any plasma transf. first 24 h 11.4 % 0 30 % 10.2 % [−0.3 %; 50.5 %]
Any platelet transf. first 24 h 7.4 % 0 20 % 6.6 % [−1.8 %; 44.7 %]
Dopamine in first 24 h 29 % 0 60 % 27.1 % [3.1 %; 57.3 %]*
Dobutamine in first 24 h 15.9 % 0 60 % 13.2 % [17.4 %; 70.7 %]**
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Severity and outcome of paediatric community-acquired
septic shock
Out of 176 cases, 5.7 % ended with severe outcome, either
death (n=8) or survival with a decrease in POPC of two or
more (n=2). Significant comorbidity was present in three of
the eight deaths (acute lymphoblastic leukaemia (n=1),
lymphoproliferative syndrome (n=1), severe pulmonary hy-
pertension (n=1)), giving a mortality of 5.1 % in the group
of children with significant comorbidity. Cardiopulmonary
resuscitation (CPR) was performed in three children during
the first hour of presentation and all died. In another three
children, CPR was performed on PICU; one child died, but
the other two survived with good outcome. Overall, 50 % of
deaths happened in the first 48 h after presentation.
Although all cases had severe sepsis and signs of de-
creased perfusion, they differed in severity and were thus
more or less likely to need medical interventions and/or end
up with severe outcome (Table 3). For instance, hypoxemia
was seen in 33.3 % and hypotension for age in 47.7 % [7].
Admission to PICU or a high dependency unit (HDU) was
deemed necessary in 65.7 % of cases, and the median length
of stay was 4 days. Total length of stay in hospital was far
longer, ranging from 0 to 71 days, with a median of 7 days.
A 7.5% were discharged to another hospital. Mechanical
ventilation and vasoactive medications were initiated in
25.9 % and 42.9 % of cases, respectively. The median
amount of fluid given in the first 6 h (excluding mainte-
nance) was 30 ml/kg, with 16.9 % receiving less then
10 ml/kg bolus and 43.3 % 40 ml/kg or more. Only
20.4 % of patients received further fluid boluses after these
6 h. Colloids were given in 18.2 % of cases and blood
products in 22.7 %. In addition, corticosteroids were given
in 14.9 % and intravenous immunoglobulin in 5.7 %.
Pneumonia was diagnosed in 27.5 % and meningitis in
15 % of cases. A diagnosis of toxic shock syndrome was
made in 7.2 %. Overall, a solitary viral aetiology was
presumed or proven in 30 children; in the remaining, sepsis
was mixed or rather bacterial in origin (proven by culture or
polymerase chain reaction (PCR) or presumed based on
typical clinical presentation). Table 4 summarizes the bac-
teria and viruses most frequently isolated. Antibiotics were
started in all but six children (96.6 %), and this almost
always within 3 h after T0. Antibiotic treatment was con-
sidered suboptimal (too late or not adequate for focus or
patient history) in only six of the 176 cases. This had no
impact on outcome in our sample, as all these cases survived
with good outcome.
Table 3 (continued)
Covariables TOTAL [n=176]: %;
mean (SD) or median (IQR)
Unknown, n Severe outcome
[n=10]
Good outcome
[n=166]
[95 % CI]
Noradrenaline in first 24 h 18.2 % 0 40 % 16.9 % [−1.1 %; 52.6 %]
Adrenaline in first 24 h 13.6 % 0 40 % 12 % [4 %; 57.2 %]*
Any corticosteroids in first 24 h 14.9 % 2 40 % 13.4 % [2.5 %; 55.9 %]*
Covariates are presented with the units or groupings used. For each variable, the number of cases is given in which that variable is ‘unknown’ (not
measured, not retraceable). For hypotension, we use the definitions from Goldstein et al. [7]. Fluid boluses are summated without taking into account
maintenance fluids. For biochemical values, the worst value on day 1 counts. Causative agents or infectious sites are positive if proven biochemically, by
culture or PCR. Depending on the properties of the variables, a Fisher exact, Student’s t or Mann–Whitney U test is used for statistical inference. The
95 % confidence intervals [CI] are given for the differences between proportions, medians or means, respectively (see “Methods” section)
Significant relations are presented in bold
*P values <0.05, **P<0.01, ***P<0.001 are indicated here and are two-sided
Table 4 Bacteria or viruses effectively isolated, in absolute numbers,
as well as the respective number of severe outcome cases
Gram-positive, n=37 Severe outcome
Streptoccocus A 5 0
Streptoccocus B 3 1
Streptoccocus pneumoniae 11 1
Staphylococcus aureus 5 1
Staphylococcus epidermidis 7 1
Other Gram-positives 6 0
Gram-negative, n=61
Neisseria meningitidis 25 1
Escherichia coli 15 0
Klebsiella spp. 4 1
Pseudomonas spp. 6 1
Other Gram-negatives 11 0
VIRAL n=19
Influenza H1N1 5 0
Proven viral origin 14 0
Multiple virus and/or bacteria isolated, n=9
Unknown, n=70 (of which presumed viral n=15) 3
In some children, more than one type of bacteria and/or virus was
isolated (most often two, but in two cases and three different agents). In
others, a bacterial or viral infection was presumed on presentation but
not identified in cultures or PCR (unknown)
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Covariates and their relation with severe outcome
We used standard parametric and non-parametric testing to
explore the relations between individual variables and the
defined severe outcome (Table 3). Variables were grouped
according to the PIRO classification: Predisposition [P],
Infection [I], Response [R], Organ dysfunction [O] [15]. In
addition, variables related to treatments initiated were
described.
We only included variables for which sufficient data were
recorded. Arterial oxygenation (pa02) was rarely available in
the first hours, so oxygen saturation by pulse oximetry was
used instead. A decreased consciousness was reported very
frequently, but only in 91 cases was a Glasgow Coma Scale
available. Overall, biochemical values were often missing,
sometimes because they were irretrievable, but most often
because they were not measured. Mixed venous saturation
was reported in only 41 cases and then only from the PICU
period. Recombinant activated protein C was started in one
2-year-old child with meningococcemia. Renal replacement
therapy was initiated in five children, all of them survived
with good outcome. Intravenous immunoglobulin was given
in eight cases, with a severe outcome in one case.
Discussion
The current study aimed to describe a true baseline state,
with parts of the resuscitation guidelines already being
implemented and without any Hawthorne effect. On its
own, this study is only exploratory in nature. With dimin-
ishing mortality and a long list of influencing variables,
more than 2,000 children per group are easily needed to
draw any strong conclusions [2, 7, 17]. Importantly, this will
also depend on how severe sepsis and septic shock is actu-
ally defined [2, 7, 10, 24]. We used an ‘early’ definition of
shock, based on signs of perfusion, allowing thus less se-
verely ill patients into the sample. It is probably in these
patients that timely and adequate treatment can make the
largest difference. Severe sepsis is a spectrum of diseases
and likewise treatments and outcomes will differ between
patients and settings [1, 6, 12].
Outcome of community-acquired septic shock
and the impact of selected covariables
The mortality in this sample was low. Moreover, only 1.2 %
of the survivors showed a substantial decrease in POPC.
One of the eight children who died did so before PICU
admission and would have been missed if PICU had been
the point of entry. As expected, the eventual patient outcome
is strongly influenced by the case severity. Defining this
severity is always difficult and flawed by issues of data
availability, measurement accuracy, definitions and differ-
ences in local practice. For instance, first-hour intubation
can be an indication of severe cardio-respiratory failure but
can also be related to local protocols of early intubation in
case of fluid resuscitation or secondary transfer. We used the
PIRO classification to identify factors of influence in sepsis
severity, need for therapy and final outcome [15].
By means of an elaborate CRF, we attempted to capture as
much of the patient history as possible. The retrospective
design precluded any definite conclusions regarding for in-
stance time delays, since this might be equally related to
decision making as to disease progression. The majority of
children presented within 24 h of first disease symptoms and
the majority of their medical interventions were done within
the first 6 h after presentation. Time delays between onset of
shock and first treatments have shown a clear relation with
outcome [3, 14, 25]. In our data, no significant effect of any
time measure on outcome was detected, perhaps because the
overall quality of care provided was high.
None of the a priori patient characteristics (P), not even
severe comorbidity, proved to be statistically related to
outcome (Table 3). This clearly differs from previous stud-
ies, where mortality in children with chronic disease was
sometimes more than twofold [2, 25]. Interestingly, both in
these studies as in ours, the number of children with a
chronic disease was well above 30 %. The nature of infec-
tion [I] also did not influence outcome. As in the study of
Herrero et al., meningococcemia was by far the most fre-
quent bacteria involved in our sample but not significantly
associated with severe outcome [8].
Why some children eventually had a severe outcome is the
result of a complex interaction between very different factors.
Without doubt, there is a significant impact of the degree of
host response [R], but for the variables we investigated we
could not confirm this. However, we did see a significant
relation between variables and outcome for those concerning
organ dysfunction [O] or provided treatments. Treatments in
turn are initiated depending on (the perception of) disease
severity and the degree of organ dysfunction at that moment,
thus only indirectly influencing outcome. A positive impact
on outcome has been shown repeatedly for EGDT, but the
question definitely remains which part of the proposed proto-
col really matters [4, 18]. In the meantime, the overall com-
pliance with EGDT in adult and paediatric ED remains low.
For instance, in our sample, only one in six cases had mixed
venous saturation measured. Early vasoactive support and
mechanical ventilation was started in 42.9 % and 25.9 %,
respectively, and the length of both was significantly related
with severe outcome. Again, this most likely reflects disease
severity, rather than being a true treatment effect. This obser-
vation as suchmakes any treatment evaluation difficult. When
we compared our data for instance with Larssen et al. who saw
a positive effect on outcome if certain practice parameters
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were met (antibiotics within first 3 h, lactate measured and
20ml/kg saline bolus in first hour), we could not confirm their
results [11]. The overall compliance rate with these parameters
was very similar (55 %) and was almost always related to the
absence of lactate measurement. However, in our population,
the more severe cases (and definitely those with a severe
outcome) actually received more fluid in the first hours, had
lactate measured and timely antibiotics given. Lactate, often
obtained from venous blood gas analysis, proved a good
predictor for outcome in our sample and might prove a less
invasive way of guiding therapy.
Strengths and weaknesses
With diminishing mortality and better overall quality of
care, it will be increasingly difficult to study paediatric
septic shock, owing to sample size, selection bias and eth-
ical issues. Existing studies are not easy to compare due to
differences in definitions, inclusion criteria, time to presen-
tation, comorbidity, health care system and treatment varia-
tions [4, 6, 10, 12]. Having the ED as the point of entry, this
study aimed to capture as well cases that died or were
resuscitated before admission. In this sample, this is not a
small group. In attempting to describe a ‘true’ picture of
paediatric community-acquired sepsis, by using tertiary re-
ferral centres, the design may have induced selection bias.
This was in part corrected by including secondary transfer
cases. The screening in each participating centre had a
different sensitivity, depending on data availability.
Despite a tendency to ‘over’-include patients, other cases
(probably the less severe ones) could have been missed. The
high accessibility of health care in most participating
countries might further have induced very early medical
intervention—avoiding the development of ‘severe sep-
sis’—or early admission with sepsis development only on
the ward. In this study, two deaths have not been included as
they were referred after more than 6 h in the initial hospital.
We chose a 6-h limit to avoid including hospital-acquired
sepsis or non-sepsis-related shock and/or having problems
with data quality [4]. Due to this approach, we might have
missed cases that developed septic shock later in their dis-
ease course or were merely referred (too) late. Finally, while
we included cases that were transported directly to ICU after
a pre-hospital intervention by a team from the participating
ED, most likely, we will have missed cases when, as is the
habit in some centres, patients with chronic comorbidity
directly go to the ward or ICU from home and so bypass
our screening.
Due to the retrospective study nature, there were often
incomplete fields in the CRF, sometimes because they were
not retraceable but more often because they were not mea-
sured. While the general medical management was quite sim-
ilar in the majority of centres, there were sometimes important
differences in the amount of monitoring and tests ordered (for
instance, blood tests, cultures or PCR). This might have in-
duced bias when evaluating the relation between these tests
and outcome as well as selection bias (case identification).
Standard severity scores (e.g. PIM, PRISM) and end points
used in other trials (e.g. shock reversal) are difficult to calculate
or define in this setting. Importantly, both PIM or PRISM and
shock reversal are highly influenced by these unknown data
(e.g. arterial blood gas) as well as by treatment decisions made
(e.g. timing of intubation). Treatment decisions in turn are
equally related to disease severity and the local system of
health-care organization.
This study was intended as a first part of a subsequent
prospective trial. It identified however several problems that
might preclude such a randomized control trial (RCT). The
relatively low prevalence and high number of identified cova-
riates will make it difficult to sufficiently power any trial. The
differences in patient trajectory between regions and centres
further complicate patient identification, thus inducing selec-
tion bias. Importantly, sepsis and shock are still poorly defined
entities with different cut-offs used in different studies. Even
with a similar clinical presentation, clearly, not every shock is
the same and should be treated the same way [12]. Ideally,
cases with too low or too high probability of survival should be
excluded, but in that situation too strict inclusion criteria would
generate results that cannot be extrapolated to the ‘true world’.
By doing this retrospective study, we tried to account for bias
from unblinding and Hawthorne effects, but these will defi-
nitely be of influence in a prospective RCT. Finally, the already
existing evidence for certain treatments (e.g. early appropriate
antibiotics) might make it ethically difficult to withhold them
in any control group, where on the other hand the costs of a
large RCT likely to fail makes this study design also disputable
[16].
It is thus our opinion that, although having their own con-
founders and difficulties, large prospective observational stud-
ies are more feasible and have the possibility to adequately
describe these complex clinical problems [22].
Conclusion
Having the ED as the point of entry, this study of children with
community-acquired septic shock aimed to also capture cases
who died or were resuscitated before admission. Indeed, many
children were seen and received treatment early in their disease
course, thus avoiding any subsequent intensive care admission.
In the majority of cases, most or all medical interventions were
performed within the first 6 h of contact.
Overall, the outcome in this true world sample was very
good. Several factors, as described within the PIRO classifica-
tion, are presumed to be of influence. Where certain variables
predispose children to become septic and shocked, we could
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only confirm an impact on severe outcome for covariates that
concern organ dysfunction or provided treatments.
This study served as a first exploratory part of a potential
prospective RCT. We however argue why we think that such
a trial might not be feasible. In our opinion, a large prospec-
tive observational study, if high in quality and using clear
definitions and inclusion criteria, can provide important
information to understand the problem of septic shock in
children. A broad international paediatric emergency medi-
cine research network should provide the necessary frame-
work to initiate this.
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